73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Cancer while pregnant is rare, but is becoming more common. Here's what researchers think is behind the rise

Cancer while pregnant is rare, but is becoming more common. Here's what researchers think is behind the rise

by Sarah Sasson and Sean Seeho,The ConversationCredit: Pixabay/CC0 Public DomainFormer winner of TV show Alone Australia Gina Chick wasdiagnosedwith breast cancer just days after fin

Cancer while pregnant is rare, but is becoming more common. Here's what researchers think is behind the rise

by Sarah Sasson and Sean Seeho,The ConversationCredit: Pixabay/CC0 Public DomainFormer winner of TV show Alone Australia Gina Chick wasdiagnosedwith breast cancer just days after fin
Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-
Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.016Anti-cancer immune cells are critical to inhibiti

Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.016Anti-cancer immune cells are critical to inhibiti
T-cell interactions vary between tumor microenvironments

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar
Researchers map the genome of testicular cancer

Researchers map the genome of testicular cancer

by Laura Oleniacz,UNC Lineberger Comprehensive Cancer CenterUNC Lineberger's Katherine Hoadley, PhD. Credit: UNC Lineberger Comprehensive Cancer CenterTesticular germ cell cancer, a disease

Researchers map the genome of testicular cancer

by Laura Oleniacz,UNC Lineberger Comprehensive Cancer CenterUNC Lineberger's Katherine Hoadley, PhD. Credit: UNC Lineberger Comprehensive Cancer CenterTesticular germ cell cancer, a disease
Unlocking the body's hidden weapon against cancer: The role of broken chromosomes

Unlocking the body's hidden weapon against cancer: The role of broken chromosomes

by Zhejiang UniversityCredit: Pixabay/CC0 Public DomainScientists have unraveled the mechanisms of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (c

Unlocking the body's hidden weapon against cancer: The role of broken chromosomes

by Zhejiang UniversityCredit: Pixabay/CC0 Public DomainScientists have unraveled the mechanisms of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (c
Genomic deletions explain why some types of melanoma resist targeted therapies

Genomic deletions explain why some types of melanoma resist targeted therapies

byCenter for Genomic RegulationCredit: CC0 Public DomainMelanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to allevia

Genomic deletions explain why some types of melanoma resist targeted therapies

byCenter for Genomic RegulationCredit: CC0 Public DomainMelanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to allevia
Researchers develop modular approach to engineering immune cells

Researchers develop modular approach to engineering immune cells

by Bara Badwan,Yale UniversityCredit: stock.adobe.comYale researchers have developed a new way to efficiently engineer immune cells, an advance which enhances the ability to fend off cancer and

Researchers develop modular approach to engineering immune cells

by Bara Badwan,Yale UniversityCredit: stock.adobe.comYale researchers have developed a new way to efficiently engineer immune cells, an advance which enhances the ability to fend off cancer and
Ancient viruses could help kill cancers

Ancient viruses could help kill cancers

by The Francis Crick InstituteHeatmap showing expression of melanoma-specific transcripts across a range of cancer types. The three columns with high expression are from melanoma samples. Credit:

Ancient viruses could help kill cancers

by The Francis Crick InstituteHeatmap showing expression of melanoma-specific transcripts across a range of cancer types. The three columns with high expression are from melanoma samples. Credit:
Study reveals pathways for aggressive prostate cancer subtype

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati
Drug combo heralds major shift in chronic lymphocytic leukemia treatment

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali
Genetic test could help fight secondary breast cancer

Genetic test could help fight secondary breast cancer

by University of SheffieldMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainThousands of breast cancer patients at risk of developing aggressive sec

Genetic test could help fight secondary breast cancer

by University of SheffieldMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainThousands of breast cancer patients at risk of developing aggressive sec